| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dbv Technologies S.A. (DBVT) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. DBVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.30M | $145.99M | - | |
| CEO | 964.0K | $19.27M | - | |
| Other | 101.5K | $2.03M | - | |
| CFO | 70.0K | $1.40M | - | |
| Other | 55.0K | $1.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Epic Bpifrance | Member Of 10% Owner Group | Sell | 3,369,093 | $4.60 | $15,484,143.17 | -12.1% | -9.6% | - | |
| Nov 21, 2025 | Mohideen Pharis48 | Chief Medical Officer | Sell | 8,120 | $2.86 | $23,206.96 | -3.8% | +53.2% | - | |
| Jul 29, 2025 | Mohideen Pharis48 | Chief Medical Officer | Sell | 464 | $2.22 | $1,030.08 | -0.4% | +63.2% | - | |
| May 22, 2025 | Mohideen Pharis48 | Chief Medical Officer | Sell | 397 | $1.84 | $730.48 | -0.4% | +11.7% | - | |
| Jan 30, 2025 | Mohideen Pharis48 | Chief Medical Officer | Sell | 600 | $0.85 | $510.00 | -0.5% | +111.5% | +407.3% | |
| Nov 25, 2024 | Mohideen Pharis48 | Chief Medical Officer | Sell | 907 | $0.55 | $503.31 | -0.4% | +64.4% | +418.4% | |
| Nov 21, 2024 | Mohideen Pharis48 | Chief Medical Officer | Sell | 2,350 | $0.54 | $1,269.00 | -2.1% | +81.9% | +463.4% | |
| Jul 29, 2024 | Mohideen Pharis48 | Chief Medical Officer | Sell | 1,785 | $0.98 | $1,749.30 | -2.2% | -13.9% | +113.0% | |
| May 24, 2024 | Mohideen Pharis48 | Chief Medical Officer | Sell | 1,042 | $1.37 | $1,424.76 | -0.6% | -24.5% | +38.0% | |
| Mar 8, 2024 | Tasse Daniel | Chief Executive Officer | Buy | 17,094 | $0.83 | $14,188.02 | New | -33.9% | -51.3% |